Paresh C Gandhi
Examiner (ID: 305)
Most Active Art Unit | 2663 |
Art Unit(s) | 2663 |
Total Applications | 1 |
Issued Applications | 1 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17183682
[patent_doc_number] => 20210330567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR USE
[patent_app_type] => utility
[patent_app_number] => 17/370074
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370074 | Compounds and compositions for use | Jul 7, 2021 | Issued |
Array
(
[id] => 17297711
[patent_doc_number] => 20210393550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
[patent_app_type] => utility
[patent_app_number] => 17/365118
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365118 | Formulation for inhibiting formation of 5-HT | Jun 30, 2021 | Issued |
Array
(
[id] => 17334744
[patent_doc_number] => 20220001075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => FLOWABLE HEMOSTATIC SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 17/365795
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365795 | FLOWABLE HEMOSTATIC SUSPENSION | Jun 30, 2021 | Pending |
Array
(
[id] => 18792599
[patent_doc_number] => 11826332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Antimicrobial compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/360966
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 19883
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360966 | Antimicrobial compositions and uses thereof | Jun 27, 2021 | Issued |
Array
(
[id] => 17140320
[patent_doc_number] => 20210308331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => MACROSCOPICALLY ALIGNABLE, INJECTABLE, SOFT HYDROGEL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/350695
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350695 | Macroscopically alignable, injectable, soft hydrogel composition | Jun 16, 2021 | Issued |
Array
(
[id] => 19423196
[patent_doc_number] => 12082580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system
[patent_app_type] => utility
[patent_app_number] => 17/304041
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 22116
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304041 | Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system | Jun 13, 2021 | Issued |
Array
(
[id] => 17140065
[patent_doc_number] => 20210308076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Methods For The Treatment Of Depression
[patent_app_type] => utility
[patent_app_number] => 17/345395
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345395 | Methods for the treatment of depression | Jun 10, 2021 | Issued |
Array
(
[id] => 18931020
[patent_doc_number] => 11883414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Methods of reducing mammographic breast density and/or breast cancer risk
[patent_app_type] => utility
[patent_app_number] => 17/344052
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 60
[patent_no_of_words] => 48649
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344052 | Methods of reducing mammographic breast density and/or breast cancer risk | Jun 9, 2021 | Issued |
Array
(
[id] => 17974362
[patent_doc_number] => 11491199
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-08
[patent_title] => Anticoagulation activity of sulfated carboxymethyl cellulose/
[patent_app_type] => utility
[patent_app_number] => 17/342593
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 10603
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342593 | Anticoagulation activity of sulfated carboxymethyl cellulose/ | Jun 8, 2021 | Issued |
Array
(
[id] => 17095313
[patent_doc_number] => 20210283104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/337952
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337952 | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER | Jun 2, 2021 | Pending |
Array
(
[id] => 19195262
[patent_doc_number] => 11992480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/327236
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 13354
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327236 | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors | May 20, 2021 | Issued |
Array
(
[id] => 17065701
[patent_doc_number] => 20210267916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
[patent_app_type] => utility
[patent_app_number] => 17/324547
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324547 | Formulation for inhibiting formation of 5-HT | May 18, 2021 | Issued |
Array
(
[id] => 19241041
[patent_doc_number] => 12011457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Selenium disulfide compositions for use in treating meibomian gland dysfunction
[patent_app_type] => utility
[patent_app_number] => 17/320731
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 9112
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320731 | Selenium disulfide compositions for use in treating meibomian gland dysfunction | May 13, 2021 | Issued |
Array
(
[id] => 19195337
[patent_doc_number] => 11992556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Pharmaceutical aerosol product for administration by oral or nasal inhalation
[patent_app_type] => utility
[patent_app_number] => 17/319655
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7377
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319655 | Pharmaceutical aerosol product for administration by oral or nasal inhalation | May 12, 2021 | Issued |
Array
(
[id] => 17272878
[patent_doc_number] => 20210379076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/308610
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308610 | ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | May 4, 2021 | Pending |
Array
(
[id] => 17020154
[patent_doc_number] => 20210244025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => ACID/ANIONIC ANTIMICROBIAL AND VIRUCIDAL COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/302284
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302284 | Acid/anionic antimicrobial and virucidal compositions and uses thereof | Apr 28, 2021 | Issued |
Array
(
[id] => 17197760
[patent_doc_number] => 20210337854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => BUILDING RESILIENCE TO COVID-19 AND ITS VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/236990
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236990 | Building resilience to Covid-19 and its variants | Apr 20, 2021 | Issued |
Array
(
[id] => 17168777
[patent_doc_number] => 20210322447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/231553
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231553 | TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES | Apr 14, 2021 | Abandoned |
Array
(
[id] => 16975308
[patent_doc_number] => 20210219545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION
[patent_app_type] => utility
[patent_app_number] => 17/221550
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221550 | Compositions and methods for long lasting disinfection | Apr 1, 2021 | Issued |
Array
(
[id] => 16961441
[patent_doc_number] => 20210212940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/217455
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17217455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/217455 | APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY | Mar 29, 2021 | Abandoned |